24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
ALS
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:11
After $30 million in losses, Arkia faces a battle over who will pay for its rescue
12:00
“My biggest concern is that organizations will give agents the ability to act faster and only then develop the ability to govern those actions”
10:20
X and Instagram account for 98% of views of antisemitic content in new study
10:06
From fake bank ads to WhatsApp traps: Inside Israel’s online investment scams
More stories
Buzz
Most popular
Daily
Weekly
1
From six-person startups to a $6.3 billion take-private: October's extraordinary month for Israeli tech exits
2
ServiceNow CEO says acquired Israeli startup Sweep helps it switch CRM customers in weeks, not years
3
Israeli digital health company TailorMed acquired in $250 million deal
4
Perion to be acquired by India’s Affle for $420 million, marking a steep fall for a once-billion-dollar Israeli company
5
Intel’s Israeli workers fear another downturn after stock collapse and deadly factory blast
More news
ALS
6 stories about ALS
Jon Medved steps down as OurCrowd CEO after ALS diagnosis
21.10.25
|
Meir Orbach
Founder passes the torch to Cali Chill as he moves into Chairman role and focuses on strategic growth.
NeuroSense Therapeutics and NeuraLight collaborate to detect ALS using AI
28.07.22
|
CTech
The collaboration between the Israeli companies will help the scientific community better understand Amyotrophic lateral sclerosis (ALS) and develop effective drugs to treat it
Mind over Matter: The man who turned himself into a cyborg to overcome ALS
13.09.20
|
Yoghev Carmel
After Peter Scott-Morgan was given a year to live, he decided to fight his fate and employed cutting edge technology to stay alive and remain human
ALS Drug Developer NeuroSense Crowdfunds $1.15 Million
05.08.19
|
Adi Pick
The company’s 1,114 new investors will jointly own a 10% stake, the company said
Kadimastem Gets FDA Orphan Drug Designation for ALS Drug
04.11.18
|
Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019
Israeli ALS Treatment Developer Recruits Kite Pharma's CSO as Board Member
05.02.18
|
Dror Reich
Nasdaq-listed BrainStorm develops stem cell therapies for degenerative neurological diseases